Structure

Physi-Chem Properties

Molecular Weight:  241.11
Volume:  255.085
LogP:  4.068
LogD:  3.647
LogS:  -5.723
# Rotatable Bonds:  2
TPSA:  34.25
# H-Bond Aceptor:  3
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.743
Synthetic Accessibility Score:  1.937
Fsp3:  0.2
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.958
MDCK Permeability:  1.6663949281792156e-05
Pgp-inhibitor:  0.375
Pgp-substrate:  0.9
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.678
30% Bioavailability (F30%):  0.766

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.502
Plasma Protein Binding (PPB):  94.2648696899414%
Volume Distribution (VD):  0.724
Pgp-substrate:  4.424070358276367%

ADMET: Metabolism

CYP1A2-inhibitor:  0.982
CYP1A2-substrate:  0.979
CYP2C19-inhibitor:  0.755
CYP2C19-substrate:  0.794
CYP2C9-inhibitor:  0.364
CYP2C9-substrate:  0.936
CYP2D6-inhibitor:  0.678
CYP2D6-substrate:  0.951
CYP3A4-inhibitor:  0.71
CYP3A4-substrate:  0.393

ADMET: Excretion

Clearance (CL):  7.149
Half-life (T1/2):  0.301

ADMET: Toxicity

hERG Blockers:  0.063
Human Hepatotoxicity (H-HT):  0.203
Drug-inuced Liver Injury (DILI):  0.878
AMES Toxicity:  0.897
Rat Oral Acute Toxicity:  0.4
Maximum Recommended Daily Dose:  0.941
Skin Sensitization:  0.888
Carcinogencity:  0.857
Eye Corrosion:  0.084
Eye Irritation:  0.985
Respiratory Toxicity:  0.958

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC131017

Natural Product ID:  NPC131017
Common Name*:   Glycozolidine
IUPAC Name:   2,6-dimethoxy-3-methyl-9H-carbazole
Synonyms:   Glycozolidine
Standard InCHIKey:  MKQKWPIESXSKSS-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C15H15NO2/c1-9-6-11-12-7-10(17-2)4-5-13(12)16-14(11)8-15(9)18-3/h4-8,16H,1-3H3
SMILES:  COc1ccc2c(c1)c1cc(C)c(cc1[nH]2)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL463555
PubChem CID:   147297
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0000210] Carbazoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO17936 Glycosmis arborea Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[15387647]
NPO17936 Glycosmis arborea Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT80 Cell Line Raji Homo sapiens Activity > 80.0 % PMID[501763]
NPT80 Cell Line Raji Homo sapiens Activity = 60.0 % PMID[501763]
NPT2 Others Unspecified Activity = 24.3 % PMID[501763]
NPT2 Others Unspecified Activity = 51.3 % PMID[501763]
NPT2 Others Unspecified Activity = 76.0 % PMID[501763]
NPT2 Others Unspecified Activity = 100.0 % PMID[501763]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC90 > 50000.0 nM PMID[501764]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC131017 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9556 High Similarity NPC162484
0.9399 High Similarity NPC193777
0.933 High Similarity NPC243834
0.933 High Similarity NPC70956
0.9278 High Similarity NPC72211
0.9194 High Similarity NPC201697
0.9167 High Similarity NPC70259
0.9111 High Similarity NPC205934
0.9111 High Similarity NPC43787
0.9048 High Similarity NPC48353
0.8973 High Similarity NPC291535
0.8973 High Similarity NPC135887
0.8973 High Similarity NPC475085
0.8973 High Similarity NPC199277
0.8973 High Similarity NPC475112
0.8927 High Similarity NPC84478
0.8919 High Similarity NPC267423
0.8912 High Similarity NPC46561
0.8907 High Similarity NPC153042
0.887 High Similarity NPC176127
0.887 High Similarity NPC212535
0.8833 High Similarity NPC242928
0.883 High Similarity NPC476106
0.8817 High Similarity NPC476044
0.8777 High Similarity NPC470930
0.8771 High Similarity NPC94943
0.8715 High Similarity NPC190007
0.8701 High Similarity NPC88363
0.8684 High Similarity NPC4687
0.8684 High Similarity NPC249583
0.8653 High Similarity NPC310211
0.8653 High Similarity NPC308137
0.8632 High Similarity NPC45190
0.8632 High Similarity NPC300156
0.861 High Similarity NPC128823
0.8579 High Similarity NPC473179
0.8564 High Similarity NPC329747
0.8564 High Similarity NPC116238
0.8526 High Similarity NPC223427
0.8525 High Similarity NPC246700
0.8515 High Similarity NPC252251
0.8505 High Similarity NPC87413
0.85 High Similarity NPC474798
0.8497 Intermediate Similarity NPC209769
0.8477 Intermediate Similarity NPC169402
0.8475 Intermediate Similarity NPC474409
0.8442 Intermediate Similarity NPC86078
0.8434 Intermediate Similarity NPC247803
0.8431 Intermediate Similarity NPC477531
0.8426 Intermediate Similarity NPC170114
0.8424 Intermediate Similarity NPC296527
0.84 Intermediate Similarity NPC477532
0.8392 Intermediate Similarity NPC208084
0.8382 Intermediate Similarity NPC209174
0.8378 Intermediate Similarity NPC76748
0.8376 Intermediate Similarity NPC470549
0.8374 Intermediate Similarity NPC473185
0.8368 Intermediate Similarity NPC329793
0.8351 Intermediate Similarity NPC13880
0.8351 Intermediate Similarity NPC251090
0.835 Intermediate Similarity NPC174760
0.835 Intermediate Similarity NPC477533
0.835 Intermediate Similarity NPC150239
0.8342 Intermediate Similarity NPC307963
0.8333 Intermediate Similarity NPC92111
0.8325 Intermediate Similarity NPC232727
0.8324 Intermediate Similarity NPC128751
0.8316 Intermediate Similarity NPC208284
0.8308 Intermediate Similarity NPC198503
0.829 Intermediate Similarity NPC285558
0.828 Intermediate Similarity NPC469497
0.828 Intermediate Similarity NPC106833
0.8272 Intermediate Similarity NPC11017
0.8272 Intermediate Similarity NPC176538
0.8265 Intermediate Similarity NPC199667
0.8265 Intermediate Similarity NPC11464
0.8256 Intermediate Similarity NPC475910
0.8256 Intermediate Similarity NPC39679
0.8252 Intermediate Similarity NPC475253
0.8235 Intermediate Similarity NPC227908
0.8232 Intermediate Similarity NPC478074
0.823 Intermediate Similarity NPC6786
0.8218 Intermediate Similarity NPC280799
0.8214 Intermediate Similarity NPC473181
0.8187 Intermediate Similarity NPC72980
0.8186 Intermediate Similarity NPC179287
0.8182 Intermediate Similarity NPC316981
0.8182 Intermediate Similarity NPC473180
0.8182 Intermediate Similarity NPC94157
0.8173 Intermediate Similarity NPC471304
0.8163 Intermediate Similarity NPC470931
0.815 Intermediate Similarity NPC3207
0.8086 Intermediate Similarity NPC473182
0.8081 Intermediate Similarity NPC123976
0.8081 Intermediate Similarity NPC167860
0.8057 Intermediate Similarity NPC473183
0.8053 Intermediate Similarity NPC475190
0.805 Intermediate Similarity NPC266931
0.805 Intermediate Similarity NPC39500
0.804 Intermediate Similarity NPC187501
0.8011 Intermediate Similarity NPC26850
0.799 Intermediate Similarity NPC121772
0.798 Intermediate Similarity NPC210828
0.798 Intermediate Similarity NPC96321
0.798 Intermediate Similarity NPC473041
0.798 Intermediate Similarity NPC86834
0.7971 Intermediate Similarity NPC202503
0.7962 Intermediate Similarity NPC277351
0.7962 Intermediate Similarity NPC473184
0.796 Intermediate Similarity NPC469592
0.796 Intermediate Similarity NPC471080
0.795 Intermediate Similarity NPC23294
0.7943 Intermediate Similarity NPC26872
0.7941 Intermediate Similarity NPC193267
0.7941 Intermediate Similarity NPC213530
0.7926 Intermediate Similarity NPC204385
0.7925 Intermediate Similarity NPC473187
0.7923 Intermediate Similarity NPC312872
0.7913 Intermediate Similarity NPC144452
0.7906 Intermediate Similarity NPC99666
0.7902 Intermediate Similarity NPC132642
0.7902 Intermediate Similarity NPC225279
0.79 Intermediate Similarity NPC303951
0.7892 Intermediate Similarity NPC184408
0.7884 Intermediate Similarity NPC46580
0.7861 Intermediate Similarity NPC9894
0.7826 Intermediate Similarity NPC280272
0.7819 Intermediate Similarity NPC62069
0.7812 Intermediate Similarity NPC280964
0.7812 Intermediate Similarity NPC141915
0.7812 Intermediate Similarity NPC114335
0.7807 Intermediate Similarity NPC206201
0.7806 Intermediate Similarity NPC315957
0.7805 Intermediate Similarity NPC469594
0.7794 Intermediate Similarity NPC152768
0.7794 Intermediate Similarity NPC148183
0.7789 Intermediate Similarity NPC66083
0.7778 Intermediate Similarity NPC473189
0.7778 Intermediate Similarity NPC314002
0.7778 Intermediate Similarity NPC310118
0.7778 Intermediate Similarity NPC60621
0.7756 Intermediate Similarity NPC305984
0.7756 Intermediate Similarity NPC314552
0.775 Intermediate Similarity NPC321428
0.7737 Intermediate Similarity NPC160381
0.7732 Intermediate Similarity NPC326634
0.7725 Intermediate Similarity NPC274640
0.7725 Intermediate Similarity NPC204717
0.7718 Intermediate Similarity NPC303658
0.7716 Intermediate Similarity NPC19872
0.7711 Intermediate Similarity NPC476465
0.7688 Intermediate Similarity NPC245816
0.7688 Intermediate Similarity NPC476138
0.768 Intermediate Similarity NPC106937
0.7673 Intermediate Similarity NPC185782
0.7672 Intermediate Similarity NPC220765
0.7659 Intermediate Similarity NPC118228
0.7653 Intermediate Similarity NPC474688
0.7647 Intermediate Similarity NPC294620
0.7644 Intermediate Similarity NPC171171
0.7641 Intermediate Similarity NPC276517
0.7638 Intermediate Similarity NPC295898
0.7637 Intermediate Similarity NPC118511
0.7636 Intermediate Similarity NPC475666
0.7626 Intermediate Similarity NPC249040
0.7626 Intermediate Similarity NPC234197
0.7619 Intermediate Similarity NPC122436
0.7619 Intermediate Similarity NPC211416
0.7614 Intermediate Similarity NPC306376
0.7598 Intermediate Similarity NPC294375
0.7594 Intermediate Similarity NPC110151
0.7591 Intermediate Similarity NPC81939
0.7582 Intermediate Similarity NPC177404
0.7577 Intermediate Similarity NPC89549
0.7576 Intermediate Similarity NPC18487
0.7563 Intermediate Similarity NPC77555
0.7562 Intermediate Similarity NPC36229
0.7562 Intermediate Similarity NPC476581
0.7562 Intermediate Similarity NPC16452
0.7561 Intermediate Similarity NPC26679
0.7559 Intermediate Similarity NPC311906
0.7559 Intermediate Similarity NPC471762
0.7553 Intermediate Similarity NPC96890
0.7553 Intermediate Similarity NPC184964
0.7536 Intermediate Similarity NPC51388
0.7535 Intermediate Similarity NPC474192
0.7535 Intermediate Similarity NPC475720
0.7534 Intermediate Similarity NPC477066
0.7525 Intermediate Similarity NPC472111
0.7513 Intermediate Similarity NPC242209
0.7512 Intermediate Similarity NPC478078
0.7512 Intermediate Similarity NPC157931
0.75 Intermediate Similarity NPC174758
0.75 Intermediate Similarity NPC477067
0.75 Intermediate Similarity NPC42591
0.75 Intermediate Similarity NPC21638
0.75 Intermediate Similarity NPC478081
0.75 Intermediate Similarity NPC469589
0.75 Intermediate Similarity NPC473540
0.75 Intermediate Similarity NPC174672

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC131017 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8737 High Similarity NPD5658 Approved
0.8511 High Similarity NPD4118 Clinical (unspecified phase)
0.8342 Intermediate Similarity NPD1304 Clinical (unspecified phase)
0.8342 Intermediate Similarity NPD1038 Approved
0.8342 Intermediate Similarity NPD3003 Approved
0.8298 Intermediate Similarity NPD3324 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD1768 Approved
0.8105 Intermediate Similarity NPD4418 Discontinued
0.801 Intermediate Similarity NPD5903 Approved
0.801 Intermediate Similarity NPD5902 Approved
0.7892 Intermediate Similarity NPD3920 Phase 2
0.7882 Intermediate Similarity NPD5612 Discontinued
0.7839 Intermediate Similarity NPD1392 Approved
0.7828 Intermediate Similarity NPD4795 Phase 2
0.7806 Intermediate Similarity NPD1739 Approved
0.7806 Intermediate Similarity NPD1740 Approved
0.7756 Intermediate Similarity NPD5164 Discontinued
0.7755 Intermediate Similarity NPD3825 Phase 3
0.775 Intermediate Similarity NPD7452 Approved
0.775 Intermediate Similarity NPD7453 Approved
0.775 Intermediate Similarity NPD7222 Phase 2
0.7729 Intermediate Similarity NPD5930 Phase 3
0.7718 Intermediate Similarity NPD5632 Approved
0.7718 Intermediate Similarity NPD6985 Discontinued
0.7711 Intermediate Similarity NPD2187 Approved
0.7711 Intermediate Similarity NPD2189 Approved
0.7684 Intermediate Similarity NPD6344 Clinical (unspecified phase)
0.7681 Intermediate Similarity NPD7194 Discontinued
0.768 Intermediate Similarity NPD802 Phase 2
0.7656 Intermediate Similarity NPD6160 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD6242 Discontinued
0.7612 Intermediate Similarity NPD8403 Phase 1
0.759 Intermediate Similarity NPD5575 Clinical (unspecified phase)
0.7581 Intermediate Similarity NPD7558 Phase 2
0.7577 Intermediate Similarity NPD5913 Phase 3
0.7577 Intermediate Similarity NPD5912 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD1325 Approved
0.7568 Intermediate Similarity NPD1326 Approved
0.7568 Intermediate Similarity NPD4724 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD6861 Clinical (unspecified phase)
0.7525 Intermediate Similarity NPD5530 Phase 1
0.7524 Intermediate Similarity NPD1322 Clinical (unspecified phase)
0.7512 Intermediate Similarity NPD5067 Phase 2
0.7512 Intermediate Similarity NPD5066 Phase 2
0.75 Intermediate Similarity NPD4511 Phase 1
0.7477 Intermediate Similarity NPD5559 Phase 2
0.7476 Intermediate Similarity NPD3815 Phase 1
0.7476 Intermediate Similarity NPD5070 Clinical (unspecified phase)
0.7476 Intermediate Similarity NPD3816 Phase 1
0.7449 Intermediate Similarity NPD3922 Approved
0.7449 Intermediate Similarity NPD3923 Approved
0.7449 Intermediate Similarity NPD3921 Approved
0.7449 Intermediate Similarity NPD3924 Approved
0.7448 Intermediate Similarity NPD5083 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD6494 Phase 2
0.7376 Intermediate Similarity NPD5669 Clinical (unspecified phase)
0.7373 Intermediate Similarity NPD4885 Approved
0.7366 Intermediate Similarity NPD8358 Approved
0.7346 Intermediate Similarity NPD3763 Approved
0.7343 Intermediate Similarity NPD4502 Phase 2
0.7333 Intermediate Similarity NPD7823 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD1954 Phase 1
0.7321 Intermediate Similarity NPD3257 Approved
0.7303 Intermediate Similarity NPD1305 Clinical (unspecified phase)
0.73 Intermediate Similarity NPD7948 Phase 1
0.7286 Intermediate Similarity NPD6491 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD5256 Discontinued
0.7264 Intermediate Similarity NPD3875 Discontinued
0.726 Intermediate Similarity NPD6220 Phase 3
0.7254 Intermediate Similarity NPD4203 Approved
0.7254 Intermediate Similarity NPD4204 Approved
0.7252 Intermediate Similarity NPD2921 Clinical (unspecified phase)
0.7245 Intermediate Similarity NPD2749 Discontinued
0.7243 Intermediate Similarity NPD7221 Approved
0.7243 Intermediate Similarity NPD7219 Approved
0.7225 Intermediate Similarity NPD6243 Phase 3
0.7225 Intermediate Similarity NPD6244 Phase 3
0.7214 Intermediate Similarity NPD5003 Discontinued
0.7214 Intermediate Similarity NPD6769 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD8364 Approved
0.7203 Intermediate Similarity NPD8363 Approved
0.72 Intermediate Similarity NPD6230 Discontinued
0.72 Intermediate Similarity NPD4349 Approved
0.72 Intermediate Similarity NPD6590 Discontinued
0.72 Intermediate Similarity NPD4350 Approved
0.7193 Intermediate Similarity NPD6503 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD484 Approved
0.7183 Intermediate Similarity NPD3258 Approved
0.7164 Intermediate Similarity NPD5512 Phase 3
0.7163 Intermediate Similarity NPD6736 Discontinued
0.7158 Intermediate Similarity NPD5680 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD7555 Discontinued
0.7155 Intermediate Similarity NPD7955 Approved
0.7155 Intermediate Similarity NPD7956 Approved
0.715 Intermediate Similarity NPD5429 Discontinued
0.7149 Intermediate Similarity NPD6963 Approved
0.7149 Intermediate Similarity NPD6964 Approved
0.7143 Intermediate Similarity NPD8396 Approved
0.7143 Intermediate Similarity NPD8365 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8395 Approved
0.7143 Intermediate Similarity NPD6790 Phase 1
0.7143 Intermediate Similarity NPD7069 Discontinued
0.7136 Intermediate Similarity NPD3354 Phase 2
0.7136 Intermediate Similarity NPD3397 Phase 2
0.7124 Intermediate Similarity NPD5483 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD4952 Phase 3
0.7123 Intermediate Similarity NPD1900 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD2916 Discontinued
0.7114 Intermediate Similarity NPD6251 Discontinued
0.7104 Intermediate Similarity NPD814 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD3402 Phase 1
0.7101 Intermediate Similarity NPD6150 Discontinued
0.7101 Intermediate Similarity NPD4305 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD4995 Approved
0.7091 Intermediate Similarity NPD4996 Approved
0.7089 Intermediate Similarity NPD3440 Clinical (unspecified phase)
0.7085 Intermediate Similarity NPD2565 Phase 2
0.7085 Intermediate Similarity NPD2564 Approved
0.7083 Intermediate Similarity NPD6824 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD6550 Discontinued
0.7075 Intermediate Similarity NPD5417 Clinical (unspecified phase)
0.7074 Intermediate Similarity NPD5482 Discontinued
0.7054 Intermediate Similarity NPD7729 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD4925 Approved
0.7042 Intermediate Similarity NPD6147 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6473 Phase 1
0.7032 Intermediate Similarity NPD3259 Approved
0.7027 Intermediate Similarity NPD4373 Phase 2
0.7025 Intermediate Similarity NPD8428 Approved
0.7025 Intermediate Similarity NPD8465 Approved
0.7025 Intermediate Similarity NPD8467 Approved
0.7025 Intermediate Similarity NPD8427 Approved
0.7025 Intermediate Similarity NPD8429 Approved
0.7025 Intermediate Similarity NPD8466 Approved
0.7018 Intermediate Similarity NPD5488 Discontinued
0.7014 Intermediate Similarity NPD5939 Approved
0.7014 Intermediate Similarity NPD5936 Approved
0.701 Intermediate Similarity NPD2727 Phase 2
0.701 Intermediate Similarity NPD5810 Discontinued
0.7005 Intermediate Similarity NPD6324 Phase 1
0.7004 Intermediate Similarity NPD7803 Approved
0.7 Intermediate Similarity NPD2125 Clinical (unspecified phase)
0.6995 Remote Similarity NPD774 Phase 3
0.6991 Remote Similarity NPD7678 Clinical (unspecified phase)
0.6986 Remote Similarity NPD7051 Phase 3
0.6986 Remote Similarity NPD7050 Clinical (unspecified phase)
0.6976 Remote Similarity NPD2151 Approved
0.6976 Remote Similarity NPD3814 Phase 1
0.6976 Remote Similarity NPD2175 Phase 3
0.6976 Remote Similarity NPD2176 Approved
0.6976 Remote Similarity NPD2177 Approved
0.6974 Remote Similarity NPD7479 Phase 2
0.6974 Remote Similarity NPD1620 Clinical (unspecified phase)
0.6971 Remote Similarity NPD4035 Approved
0.6971 Remote Similarity NPD4039 Approved
0.6971 Remote Similarity NPD4037 Approved
0.6971 Remote Similarity NPD31 Approved
0.6971 Remote Similarity NPD4034 Approved
0.6971 Remote Similarity NPD4033 Approved
0.6971 Remote Similarity NPD32 Approved
0.6971 Remote Similarity NPD4122 Approved
0.6971 Remote Similarity NPD4036 Approved
0.6971 Remote Similarity NPD4038 Approved
0.697 Remote Similarity NPD4889 Approved
0.6968 Remote Similarity NPD8512 Phase 3
0.6963 Remote Similarity NPD6803 Clinical (unspecified phase)
0.6961 Remote Similarity NPD6988 Phase 1
0.6961 Remote Similarity NPD2952 Discontinued
0.696 Remote Similarity NPD4876 Phase 3
0.696 Remote Similarity NPD4875 Phase 3
0.6959 Remote Similarity NPD4354 Approved
0.6957 Remote Similarity NPD3835 Phase 3
0.6957 Remote Similarity NPD3833 Phase 3
0.6957 Remote Similarity NPD6208 Discontinued
0.6955 Remote Similarity NPD4328 Approved
0.6952 Remote Similarity NPD7672 Approved
0.6952 Remote Similarity NPD7671 Approved
0.6948 Remote Similarity NPD4457 Phase 2
0.6947 Remote Similarity NPD5905 Phase 1
0.6946 Remote Similarity NPD3810 Clinical (unspecified phase)
0.6944 Remote Similarity NPD1592 Phase 3
0.6941 Remote Similarity NPD7719 Discontinued
0.6937 Remote Similarity NPD6962 Phase 2
0.6935 Remote Similarity NPD5617 Suspended
0.6934 Remote Similarity NPD5416 Discontinued
0.6931 Remote Similarity NPD6569 Phase 2
0.6923 Remote Similarity NPD7710 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6991 Approved
0.6916 Remote Similarity NPD6140 Clinical (unspecified phase)
0.6915 Remote Similarity NPD2410 Phase 2
0.6911 Remote Similarity NPD8460 Approved
0.6911 Remote Similarity NPD8426 Approved
0.6911 Remote Similarity NPD8425 Approved
0.6911 Remote Similarity NPD8459 Approved
0.6904 Remote Similarity NPD7414 Clinical (unspecified phase)
0.6901 Remote Similarity NPD3330 Phase 1
0.6901 Remote Similarity NPD6202 Discontinued
0.69 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6894 Remote Similarity NPD8091 Phase 3
0.6892 Remote Similarity NPD5801 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data